Brett Swansiger, Chief Commercial Officer at ANGLE, discusses the importance of liquid biopsies in precision medicine trials for cancer. Challenges in the oncology clinical trials space The oncology market is a key growth driver for the pharma industry, with global drug revenues expected to reach US$390 billion by 2027 and the annual number of […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!
